These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19807804)

  • 1. If shrimps had lips, they could whistle ..
    Kreis J; Kaiser T; Wieseler B
    J Am Geriatr Soc; 2009 Oct; 57(10):1947; author reply 1947-8. PubMed ID: 19807804
    [No Abstract]   [Full Text] [Related]  

  • 2. Another perspective on the memantine graphs: clinical vs. statistical significance.
    Davis S
    Med Health R I; 2005 Jan; 88(1):12-4; discussion 14. PubMed ID: 15779549
    [No Abstract]   [Full Text] [Related]  

  • 3. Covariate adjustment increases statistical power in randomized controlled trials.
    Lingsma H; Roozenbeek B; Steyerberg E;
    J Clin Epidemiol; 2010 Dec; 63(12):1391; author reply 1392-3. PubMed ID: 20800991
    [No Abstract]   [Full Text] [Related]  

  • 4. Misleading comparisons: the fallacy of comparing statistical significance.
    Sainani K
    PM R; 2010 Jun; 2(6):559-62. PubMed ID: 20630442
    [No Abstract]   [Full Text] [Related]  

  • 5. Dropouts and missing data in psychiatric clinical trials.
    Potkin SG; Siu CO
    Am J Psychiatry; 2009 Nov; 166(11):1295; author reply 1295-6. PubMed ID: 19884237
    [No Abstract]   [Full Text] [Related]  

  • 6. A neglected issue in interpretation of results of randomized controlled trials: informative censoring.
    Gorouhi F; Khatami A; Davari P
    Dermatol Online J; 2009 Jan; 15(1):13. PubMed ID: 19281718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of the methodology in cluster randomized trials].
    Kramar A; Bonnetain F; Mathoulin-PĂ©lissier S
    Bull Cancer; 2008 Dec; 95(12):1141-2. PubMed ID: 19108340
    [No Abstract]   [Full Text] [Related]  

  • 8. Discussion of "Identifiability and estimation of causal effects in randomized trials with noncompliance and completely nonignorable missing data".
    Small DS; Cheng J
    Biometrics; 2009 Sep; 65(3):682-6; discussion 689-91. PubMed ID: 18759846
    [No Abstract]   [Full Text] [Related]  

  • 9. Subgroup analyses: primary and secondary.
    Detsky AS; Naglie IG
    ACP J Club; 1995; 122(3):A12-4. PubMed ID: 7728420
    [No Abstract]   [Full Text] [Related]  

  • 10. Statistical treatment of withdrawal in trials of anti-dementia drugs.
    Mackinnon A
    Lancet; 2008 Oct; 372(9647):1382-3; author reply 1383. PubMed ID: 18940460
    [No Abstract]   [Full Text] [Related]  

  • 11. Why don't mercedes benz publish randomized trials?
    O'Brien T; Viney R; Doherty A; Thomas K
    BJU Int; 2010 Feb; 105(3):293-5. PubMed ID: 19888986
    [No Abstract]   [Full Text] [Related]  

  • 12. What is an intention to treat analysis?
    Cipriani A; Barbui C
    Epidemiol Psichiatr Soc; 2008; 17(1):26-7. PubMed ID: 18444454
    [No Abstract]   [Full Text] [Related]  

  • 13. Is there another way to take account of noncompliance in randomized controlled trials?
    Hewitt CE; Torgerson DJ; Miles JN
    CMAJ; 2006 Aug; 175(4):347. PubMed ID: 16908892
    [No Abstract]   [Full Text] [Related]  

  • 14. [Statistics--lying, but properly].
    Bias R
    Wien Med Wochenschr; 1998; 148(1-2):30-1. PubMed ID: 9642762
    [No Abstract]   [Full Text] [Related]  

  • 15. Discussions.
    Vansteelandt S
    Biometrics; 2009 Sep; 65(3):686-9; discussion 689-91. PubMed ID: 18759845
    [No Abstract]   [Full Text] [Related]  

  • 16. Fallacies in clinical cardiovascular trials.
    Swedberg K
    Heart; 2009 Sep; 95(17):1464-8. PubMed ID: 19684197
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical trials methodology: randomization, intent-to-treat, and random-effects regression.
    Atkins DC
    Depress Anxiety; 2009; 26(8):697-700. PubMed ID: 19658122
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies should report estimates of treatment effects with confidence intervals.
    Cummings P
    Arch Pediatr Adolesc Med; 2007 May; 161(5):518-9. PubMed ID: 17485633
    [No Abstract]   [Full Text] [Related]  

  • 19. [Challenging pharmacotherapy in dementia].
    Ihl R
    MMW Fortschr Med; 2009 Mar; 151(13):46-8. PubMed ID: 19504818
    [No Abstract]   [Full Text] [Related]  

  • 20. Post-marketing studies: the Italian CRONOS project.
    Raschetti R; Maggini M; Vanacore N
    Int J Geriatr Psychiatry; 2003 Oct; 18(10):962; author reply 963. PubMed ID: 14533130
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.